Dr. Sarah Hernandez is the Director of Research Programs at the Hereditary Disease Foundation (HDF). She carried out her ...

For many with Huntington’s disease, recognising faces, navigating familiar places, or reading can be difficult. Scientists studied how and when HD affects how the brain processes what we see—crucial ...

A new study shows that lowering MSH3, a key DNA repair protein, with antisense oligonucleotide (ASO) therapy can stop CAG repeat expansions in HD patient-derived brain cells. This could be a promising ...

Huntington’s disease research news. In plain language. Written by scientists. For the global HD community. This is a fallback page – if you see it something has gone wrong – email [email protected] with ...

Huntington’s disease research news. In plain language. Written by scientists. For the global HD community. This is a fallback page – if you see it something has gone wrong – email [email protected] with ...

Huntington’s disease research news. In plain language. Written by scientists. For the global HD community. This is a fallback page – if you see it something has gone wrong – email [email protected] with ...

Huntington’s disease research news. In plain language. Written by scientists. For the global HD community. This is a fallback page – if you see it something has gone wrong – email [email protected] with ...

Hidden twists in the Huntington’s disease gene could shift symptoms by over a decade! Scientists have uncovered rare “genetic ...

Huntington’s disease disrupts genetic "traffic lights," keeping genes green when they should be red. These genetic traffic ...

Votoplam, the daily pill from PTC Therapeutics, has met its primary endpoint in the PIVOT-HD clinical trial - it can lower ...